|
 Travellers who have had the Pfizer Inc-BioNTech shot or the Moderna
Inc and Johnson & Johnson vaccines can submit proof as part of the
documentation needed for entry into China, the Chinese embassy in
Washington said in an April 16 statement.
The guidance suggests the beginnings of an easing in travel
requirements.
The world's second-largest economy has yet to approve vaccines
developed by non-Chinese drug makers for use domestically, although
the Wall Street Journal reported on Friday that China was planning
to authorise the BioNTech COVID-19 vaccine by July.
BioNTech's Chinese partner Fosun Pharma has sole marketing rights in
Greater China and the German company partners with Pfizer in other
parts of world.
[to top of second column] |
 Other Chinese embassies that
accept non-Chinese vaccination records include
the embassy in Iraq. It said in March it would
accept any COVID-19 vaccine approved in Iraq,
which has given the emergency-use nod to
vaccines from China's Sinopharm and Britain's
AstraZeneca.
China's Foreign Minister Wang Yi said last month
China was willing to hold talks with other
countries over mutual recognition of the Chinese
QR health code, which would contain a digital
certificate of COVID-19 vaccination.
(Reporting by Ryan Woo; Editing by Edwina Gibbs)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
